These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 4354931)

  • 1. 13C nuclear magnetic resonance studies of the conformation of the X-pro bond in the oligopeptide hormones, thyrotropin-releasing hormone, luteinizing hormone-releasing factor, angiotensin and melanocyte-stimulating hormone release-inhibiting factor.
    Deslauriers R; Walter R; Smith IC
    Biochem Biophys Res Commun; 1973 Jul; 53(1):244-50. PubMed ID: 4354931
    [No Abstract]   [Full Text] [Related]  

  • 2. Carbon-13 NMR studies of peptide hormones and their components.
    Smith IC; Deslauriers R; Saitô H; Walter R; Garrigou-Lagrange C; McGregor H; Sarantakis D
    Ann N Y Acad Sci; 1973 Dec; 222():597-627. PubMed ID: 4361873
    [No Abstract]   [Full Text] [Related]  

  • 3. Conformational mobility of the pyrrolidine ring of proline in peptides and peptide hormones as manifest in carbon 13 spin-lattice relaxation times.
    Deslauriers R; Smith IC; Walter R
    J Biol Chem; 1974 Nov; 249(21):7006-10. PubMed ID: 4371430
    [No Abstract]   [Full Text] [Related]  

  • 4. Inactivation of melanocyte-stimulating hormone release-inhibiting factor by a manganese-stimulated bovine brain aminopeptidase.
    Simmons WH; Brecher AS
    J Biol Chem; 1973 Aug; 248(16):5780-4. PubMed ID: 4353274
    [No Abstract]   [Full Text] [Related]  

  • 5. Intramolecular motion in peptide determined by 13C NMR: a spin-lattice relaxation time-study on MSH-release-inhibiting factor.
    Deslauriers R; Walter R; Smith IC
    FEBS Lett; 1973 Nov; 37(1):27-32. PubMed ID: 4585031
    [No Abstract]   [Full Text] [Related]  

  • 6. Studies on the inhibition of oxotremorine induced tremor by a melanocyte-stimulating hormone release-inhibiting factor, thyrotropin releasing hormone and related peptides.
    Castensson S; Sievertsson H; Lindeke B; Sum CY
    FEBS Lett; 1974 Aug; 44(1):101-5. PubMed ID: 4212370
    [No Abstract]   [Full Text] [Related]  

  • 7. Chemistry of the hypothalamic releasing factors--studies on structure-function relationships.
    Vale W; Grant G; Guillemin R
    Front Neuroendocrinol; 1973; 0(0):375-413. PubMed ID: 4369859
    [No Abstract]   [Full Text] [Related]  

  • 8. [Hypothalamic releasing and inhibiting hormones].
    Vanha-Perttula T
    Duodecim; 1973 Oct; 20(1):1282-98. PubMed ID: 4361282
    [No Abstract]   [Full Text] [Related]  

  • 9. 13C-nuclear magnetic resonance study of [85% 13C-enriched proline]thyrotropin releasing factor: 13C-13C vicinal coupling constants and conformation of the proline residue.
    Haar W; Fermandjian S; Vicar J; Blaha K; Fromageot P
    Proc Natl Acad Sci U S A; 1975 Dec; 72(12):4948-52. PubMed ID: 813218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behavioral effects of thyrotropin releasing hormone in animals and man: a generic hypothesis.
    Prange AJ; Wilson IC
    Psychopharmacol Bull; 1975 Jan; 11(1):22-4. PubMed ID: 804704
    [No Abstract]   [Full Text] [Related]  

  • 11. Hypothalamic regulatory hormones.
    Schally AV; Coy DH; Meyers CA
    Annu Rev Biochem; 1978; 47():89-128. PubMed ID: 28075
    [No Abstract]   [Full Text] [Related]  

  • 12. [Progress in the study of hypothalamic hormones].
    Ito T
    Horumon To Rinsho; 1975 Jan; 23(1):1-5. PubMed ID: 168014
    [No Abstract]   [Full Text] [Related]  

  • 13. [Hypophysiotropic factors, hypothalamus "hormone"].
    Smelik PG
    Ned Tijdschr Geneeskd; 1975 Aug; 119(32):1240-6. PubMed ID: 238160
    [No Abstract]   [Full Text] [Related]  

  • 14. Hypothalamic releasing factors and Parkinson disease.
    Chase TN; Woods AC; Lipton MA; Morris CE
    Arch Neurol; 1974 Jul; 31(1):55-6. PubMed ID: 4209275
    [No Abstract]   [Full Text] [Related]  

  • 15. [Releasing hormone].
    Yanaibara N
    Horumon To Rinsho; 1973 Nov; 21(11):1073-8. PubMed ID: 4205272
    [No Abstract]   [Full Text] [Related]  

  • 16. The present concept of the nature of hypothalamic hormones stimulating and inhibiting the release of pituitary hormones.
    Schally AV; Kastin AJ
    Triangle; 1969; 9(1):19-25. PubMed ID: 4980829
    [No Abstract]   [Full Text] [Related]  

  • 17. Site of inactivation of melanocyte-stimulating hormone-release-inhibiting hormone by human plasma.
    Nair RM; Redding TW; Kastin AJ; Schally AV
    Biochem Pharmacol; 1973 Aug; 22(15):1915-9. PubMed ID: 4578947
    [No Abstract]   [Full Text] [Related]  

  • 18. Melanocyte-stimulating hormone and parkinsonism: the role of hypothalamic releasing factors.
    Sandler M; Goodwin BL; Leask BG; Ruthven CR
    Lancet; 1973 Mar; 1(7803):612. PubMed ID: 4120682
    [No Abstract]   [Full Text] [Related]  

  • 19. Chemistry of releasing hormones.
    Sandow J
    J Endocrinol; 1973 Aug; 58(2):32-3. PubMed ID: 4199267
    [No Abstract]   [Full Text] [Related]  

  • 20. Isolation and structure of hypothalamic MSH release-inhibition hormone.
    Nair RM; Kastin AJ; Schally AV
    Biochem Biophys Res Commun; 1971 Jun; 43(6):1376-81. PubMed ID: 4398196
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.